SANOFI BANGLADESH LIMITED CHANGED FROM SANOFI AVENTIS BANGLADESH LTD

Company Introduction:

SANOFI BANGLADESH LIMITED, formerly known as SANOFI AVENTIS BANGLADESH LTD, is a prominent pharmaceutical company in Bangladesh. It operates as a subsidiary of Sanofi, a global healthcare leader based in France. The company is involved in the manufacturing, marketing, and distribution of a diverse portfolio of pharmaceutical products, including medicines, vaccines, and consumer healthcare solutions, serving the healthcare needs of the Bangladeshi market.

Nature of Business:

SANOFI BANGLADESH LIMITED primarily operates as a manufacturer and distributor of pharmaceutical products. Therefore, it is categorized as a factory (manufacturer) with integrated distribution capabilities.

Sanofi Bangladesh Limited, formerly Sanofi Aventis Bangladesh Ltd, manufactures or sells a diverse portfolio of pharmaceutical products across several key therapeutic areas. These include:

Diabetes Care:

Insulin products such as Lantus, Apidra, and Toujeo.

Oral antidiabetic medications including Amaryl.

Cardiovascular and Thrombosis:

Antiplatelet agents like Plavix.

Anticoagulants such as Clexane.

Central Nervous System:

Hypnotics including Stilnox.

Anxiolytics and anticonvulsants such as Rivotril.

Vaccines:

A range of vaccines for infectious diseases, covering influenza, polio, diphtheria, tetanus, pertussis, and meningitis.

Other Therapeutic Areas:

Specialized treatments for rare diseases.

Oncology products for cancer treatment.

General medicine products addressing various health conditions.